Data Foundry

Drug recalls 2019

MethylPREDNISolone Tablets — Class II drug recall D-1448-2019

Terminated recall by Zydus Pharmaceuticals USA Inc, reported 2019-06-26, distributed nationwide. CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Recall numberD-1448-2019
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmZydus Pharmaceuticals USA Inc, Pennington, NJ, United States
Recall initiated2019-05-06
Classified2019-07-01
Reported by FDA2019-06-26
Terminated2021-09-16
DistributedNationwide (US)
Reason classescgmp
NDC68382-0916, 68382-0916-01, 68382-0916-05, 68382-0916-34, 68382-0917, 68382-0917-01, 68382-0917-05, 68382-0917-11, 68382-0917-30, 68382-0917-77, 68382-0918, 68382-0918-01, 68382-0918-05, 68382-0918-18, 68382-0918-30, 68382-0918-77, 68382-0919, 68382-0919-01, 68382-0919-05, 68382-0919-11, 68382-0919-30, 68382-0919-77
Lot numbersFEB-20, JUL-20, JUN-20, M800144, M800145, M808193, M811096

Product

MethylPREDNISolone Tablets, USP, 4 mg, 100 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India NDC 68382-916-01

Reason for recall

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1448-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.